Current insights into the pathophysiology of irritable bowel syndrome

Current Gastroenterology Reports

Volumn 5, Issue 4, 2003, Pages 331-336

  Schwetz, Ines ^a   Bradesi, Sylvie ^a   Mayer, Emeran A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID RECEPTOR; NALOXONE; NORADRENALIN; OPIATE ANTAGONIST; PROSTAGLANDIN E2;

ABDOMINAL PAIN; CENTRAL NERVOUS SYSTEM FUNCTION; CHRONIC INFLAMMATION; DISEASE EXACERBATION; GASTROINTESTINAL MOTILITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IRRITABLE COLON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REMISSION; REVIEW; SYMPTOMATOLOGY; IMMUNOLOGY;

COLONIC DISEASES, FUNCTIONAL; HUMANS;

EID: 0042831257     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-003-0071-1     Document Type: Review

References (65)

1. Drossman DA, Camilleri M, Mayer EA, Whitehead WE: AGA technical review on irritable bowel syndrome. Gastroenterology 2002, 123:2108-2131.
2. Mayer EA, Collins SM: Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002, 122:2032-2048.
3. Mayer EA, Gebhart GF: Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994, 107:271-293.
4. Bennett EJ, Tennant CC, Piesse C, et al.: Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut 1998, 43:256-261.
5. Collins SM: A case for an immunological basis for irritable bowel syndrome. Gastroenterology 2002, 122:2078-2080.
6. Gwee KA, Graham JC, McKendrick MW, et al.: Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996, 347:150-153.
7. Gwee KA, Leong YL, Graham C, et al.: The role of psychological and biological factors in postinfective gut dysfunction. Gut 1999, 44:400-406.
8. Chadwick VS, Chen W, Shu D, et al.: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002, 122:1778-1783.
9. Spiller RC, Jenkins D, Thornley JP, et al.: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acure Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000, 47:804-811.
10. Tornblom H, Lindberg G, Nyberg B, Veress B: Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndrome. Gastroenterology 2002, 123:1972-1979.
11. Barbara G, De Giorgio R, Deng Y, et al.: Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology 2001, 120:1729-1736.
12. De Giorgio R, Barbara G, Blennerhassett P, et al.: Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat. Gut 2001, 49:822-827.
13. Naliboff BD, Derbyshire SW, Munakata J, et al.: Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 2001, 63:365-375.
14. Mertz H, Morgan V, Tanner G, et al.: Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology 2000, 118:842-848.
15. Bonaz B, Baciu M, Papillon E, et al.: Central processing of rectal pain in patients with irritable bowel syndrome: an fMRI study. Am J Gastroenterol 2002, 97:654-661.
16. Coutinho SV, Plotsky PM, Sablad M, et al.: Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol 2002, 282:G307-G316.
17. Spiller RC: Role of nerves in enteric infection. Gut 2002, 51:759-762.
18. Barbara G, De Giorgio R, Stanghellini V, et al.: A role for inflammation in irritable bowel syndrome? Gut 2002, 51(Suppl 1):i41-i44.
19. Mayer EA, Naliboff BD, Chang L, Coutinho SV: V. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2001, 280:G519-G524.
20. Mertz H: Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans. Gut 2002, 51 (Suppl 1):i29-i33.
21. Mertz H, Naliboff B, Munakata J, et al.: Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109:40-52.
22. Bouin M, Plourde V, Boivin M, et al.: Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002, 122:1771-1777.
23. Chang L, Munakata J, Mayer EA, et al.: Perceptual responses in patients with inflammatory and functional bowel disease. Gut 2000, 47:497-505.
24. Loening-Baucke V, Metcalf AM, Shirazi S: Anorectal manometry in active and quiescent ulcerative colitis. Am J Gastroenterol 1989, 84:892-897.
25. Rao SS, Read NW, Davison PA, et al.: Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis. Gastroenterology 1987, 93:1270-1275.
26. Fass R, Naliboff B, Higa L, et al.: Differential effect of long-term esophageal acid exposure on mechanosensitivity and chemosensitivity in humans. Gastroenterology 1998, 115:1363-1373.
27. Mertz H, Fullerton S, Naliboff B, Mayer EA: Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998, 42:814-822.
28. Chang L, Mayer EA, Johnson T, et al.: Differences in somatic perception in female patients with irritable bowel syndrome with and without fibromyalgia. Pain 2000, 84:297-307.
29. Mayer EA: The neurobiology of stress and gastrointestinal disease. Gut 2000, 47:861-869.
30. Matthews SG: Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 2002, 13:373-380.
31. Ladd CO, Huot RL, Thrivikraman KV, et al.: Long-term behavioral and neuroendocrine adaptations to adverse early experience. In The Biological Basis for Mind Body Interactions. Edited by Mayer EA, Saper CB. Amsterdam: Elsevier; 2000:81-103.
32. Fuchs E, Flugge G: Modulation of binding sites for corticotropin-releasing hormone by chronic psychosocial stress. Psychoneuroendocrinology 1995, 20:33-51.
33. Heim C, Ehlert U, Hellhammer DH: The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
34. Whitehead M, Holland P: What puts children of lone parents at a health disadvantage? Lancet 2003, 361:271.
35. Lowman BC, Drossman DA, Cramer EM, McKee DC: Recollection of childhood events in adults with irritable bowel syndrome. J Clin Gastroenterol 1987, 9:324-330.
36. Bush G, Vogt BA, Holmes J, et al.: Dorsal anterior cingulate cortex: a role in reward-based decision-making. Proc Natl Acad Sci U S A 2002, 99:523-528.
37. Mayberg HS: Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci 1994, 6:428-442.
38. Petrovic P, Ingvar M: Imaging cognitive modulation of pain processing. Pain 2002, 95:1-5.
39. Zhuo M, Gebhart GF: Facilitation and attenuation of a visceral nociceptive reflex from the rostroventral medulla in the rat. Gastroenterology 2002, 122:1007-1019.
40. Porreca F, Ossipov MH, Gebhart GF: Chronic pain and medullary descending facilitation. Trends Neurosci 2002, 25:319-325.
41. Chang L, Berman S, Mayer EA, et al.: Brain responses to visceral and somatic stimuli in patients with irritable bowel syndrome with and without fibromyalgia. Am J Gastroenterol 2003, in press.
42. Kalinichev M, Easterling KW, Plotsky PM, Holtzman SG: Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats. Pharmacol Biochem Behav 2002, 73:131-140.
43. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB: The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 1999, 160:1-12.
44. Caldji C, Francis D, Sharma S, et al.: The effects of early rearing environment on the development of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. Neuropsychopharmacology 2000, 22:219-229.
45. Soderholm JD, Yates DA, Gareau MG, et al.: Neonatal maternal separation predisposes adult rats to colonic barrier dysfunction in response to mild stress. Am J Physiol Gastrointest Liver Physiol 2002, 283:G1257-G1263.
46. Isgar B, Harman M, Kaye MD, Whorwell PJ: Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983, 24:190-192.
47. Simren M, Axelsson J, Abrahamsson H, et al.: Symptoms of irritable bowel syndrome in inflammatory bowel disease in remission and relationship to psychological factors [abstract]. Gastroenterology 2000, 118:A702.
48. Annese V, Bassotti G, Napolitano G, et al.: Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 1997, 32:1107-1117.
49. Bernstein CN, Niazi N, Robert M, et al.: Rectal afferent function in patients with inflammatory and functional intestinal disorders. Pain 1996, 66:151-161.
50. Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997, 314:779-782.
51. Bergin AJ, Read NW: The effect of preliminary bowel preparation on a simple test of colonic transit in constipated subjects. Int J Colorectal Dis 1993, 8:75-77.
52. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993, 38:1590-1595.
53. O'Sullivan M, Clayton N, Breslin NP, et al.: Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000, 12:449-457.
54. Tibble JA, Sigthorsson G, Foster R, et al.: Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002, 123:450-460.
55. Chan J, Gonsalkorale WM, Perrey C, et al.: IL-1O and TGF-B genotypes in irritable bowel syndrome: evidence to support an inflammatory component [abstract].? Gastroenterology 2000, 118:A184.
56. Vallance BA, Blennerhassett PA, Deng Y, et al.: IL-5 contributes to worm expulsion and muscle hypercontractility in a primary T. spiralis infection. Am J Physiol 1999, 277:G400-G408.
57. Galeazzi F, Haapala EM, van Rooijen N, et al.: Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. Am J Physiol Gastrointest Liver Physiol 2000, 278:G259-G265.
58. Der T, Bercik P, Donnelly G, et al.: Interstitial cells of cajal and inflammation-induced motor dysfunction in the mouse small intestine. Gastroenterology 2000, 119:1590-1599.
59. Barbara G, Vallance BA, Collins SM: Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice. Gastroenterology 1997, 113:1224-1232.
60. Vallance BA, Blennerhassett PA, Collins SM: Increased intestinal muscle contractility and worm expulsion in nematode-infected mice. Am J Physiol 1997, 272:G321-G327.
61. Tache Y, Martinez V, Million M, Wang L: Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors. Am J Physiol Gastrointest Liver Physiol 2001, 280:G173-G177.
62. Mayer EA, Naliboff B, Munakata J: The evolving neurobiology of gut feelings. In The Biological Basis for Mind Body Interactions. Edited by Mayer EA, Saper CB. Amsterdam: Elsevier; 2000:195-206.
63. Watkins LR, Wiertelak EP, Goehler LE, et al.: Neurocircuitry of illness-induced hyperalgesia. Brain Res 1994, 639:283-299.
64. Maier SF, Watkins LR: Cytokines for psychologists: implications and bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998, 105:83-107.
65. Drossman DA, Corazziari E, Talley NJ, et al., eds: Rome II: The Functional Gastrointestinal Disorders. Diagnosis, Pathophysiology and Treatment: A Multinational Consensus, edn 2. McLean, VA: Degnon Associates; 2000.